In Brief: Electronic QC controls
This article was originally published in The Gray Sheet
Executive SummaryElectronic QC controls: i-Stat's hand-held, automated blood chemistry analyzer was not referenced in an Oct. 13 Health Care Financing Administration memo sent to HCFA regional offices to "clarify and define" surveyor guidelines on electronic quality control in quantitative automated analyzers. Another undated version of the memo, cited by "The Gray Sheet" (Oct. 30, I&W-1), referenced the i-Stat device. The Oct. 13 memo notes that the use of electronic quality controls in quantitative automated analyzers "will be re-evaluated for the final, final" regulations for the Clinical Laboratory Improvement Amendments of 1988...
You may also be interested in...
The Swiss giant is hoping to get seven more approvals for its blockbuster immunology drug over the next 10 years.
Cadila has filed for approval of saroglitazar for NASH in India. The drug, which could emerge as the first medicine for the indication if approved, is already being used by a million Indian patients for diabetic dyslipidemia and hypertriglyceridemia.
It has been a long and sometimes tortuous development path for Lupuzor but ImmuPharma's chief executive tells Scrip the company's faith in the lupus drug is bearing fruit.